Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
European Journal of Clinical Investigation|June 16, 2009
Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cellsI Petrini, S Pacini, M Petrini, et al.Respiratory Medicine|May 8, 2007
Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenonF Marcucci, G Passalacqua, G W Canonica, et al.International Journal of Laboratory Hematology|July 21, 2015
Real-Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasmsG Fontanelli, C Baratè, E Ciabatti, et al.Journal of Neuroimmunology|December 30, 2023
Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistanceC Milano, M Montali, S Barachini, et al.British Journal of Cancer|May 14, 2009
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancerE Vasile, G Masi, L Fornaro, et al.Cell Death & Disease|July 25, 2012
Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumorsI Petrini, P S Meltzer, P A Zucali, et al.Lung Cancer (Amsterdam, Netherlands)|January 3, 2013
Reproducibility of the WHO classification of thymomas: practical implicationsP A Zucali, L Di Tommaso, I Petrini, et al.ESMO Open|June 11, 2021
Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)F Conforti, M Marino, V Vitolo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2024
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)C Proto, M Ganzinelli, S Manglaviti, et al.Pageof 1